LIVE/DEAD Viability/Cytotoxicity Kit, for mammalian cells and 3 more items

Life Technologies Corporation has been awarded a purchase order (A207_PO-0450069) by the University of Virginia in Virginia on June 17, 2026, valued at $2,084.98. The contract encompasses the procurement of specialized life science research reagents and assay kits for delivery to Samuel Agro. The line items include a Live/Dead Viability/Cytotoxicity Kit for mammalian cell analysis ($596.96), two Alexa Fluor fluorescent phalloidin conjugates—one Alexa Fluor 647 far-red variant at 650/668 nanometers ($520.50) and one Alexa Fluor 555 orange variant at 555/565 nanometers ($528.00)—and Human Vascular Endothelial Growth Factor-165 (VEGF-165) Recombinant Protein from PeproTech ($439.52).

These products are precision biochemical tools commonly utilized in cellular and molecular biology research applications, including cell viability assessment, cytoskeletal imaging, and protein analysis. The procurement represents a single transaction for laboratory supplies necessary to support research activities at the University of Virginia. No distinct period of performance is specified in the available documentation beyond the award date of June 17, 2026.